- Home
- SGMO vs XBP Comparison
SGMO vs XBP Comparison
Compare SGMO & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- XBP
- Stock Information
- Founded
- SGMO 1995
- XBP 2020
- Country
- SGMO United States
- XBP United States
- Employees
- SGMO N/A
- XBP N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- XBP Business Services
- Sector
- SGMO Health Care
- XBP Consumer Discretionary
- Exchange
- SGMO Nasdaq
- XBP Nasdaq
- Market Cap
- SGMO 122.8M
- XBP 134.0M
- IPO Year
- SGMO 2000
- XBP N/A
- Fundamental
- Price
- SGMO $0.68
- XBP $0.76
- Analyst Decision
- SGMO Strong Buy
- XBP
- Analyst Count
- SGMO 7
- XBP 0
- Target Price
- SGMO $5.29
- XBP N/A
- AVG Volume (30 Days)
- SGMO 5.4M
- XBP 639.9K
- Earning Date
- SGMO 11-11-2025
- XBP 11-11-2025
- Dividend Yield
- SGMO N/A
- XBP N/A
- EPS Growth
- SGMO N/A
- XBP N/A
- EPS
- SGMO N/A
- XBP N/A
- Revenue
- SGMO $81,706,000.00
- XBP $148,332,000.00
- Revenue This Year
- SGMO $28.47
- XBP N/A
- Revenue Next Year
- SGMO N/A
- XBP N/A
- P/E Ratio
- SGMO N/A
- XBP N/A
- Revenue Growth
- SGMO 565.52
- XBP 0.23
- 52 Week Low
- SGMO $0.41
- XBP $0.42
- 52 Week High
- SGMO $3.18
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- SGMO 66.82
- XBP 45.39
- Support Level
- SGMO $0.65
- XBP $0.76
- Resistance Level
- SGMO $0.73
- XBP $0.86
- Average True Range (ATR)
- SGMO 0.06
- XBP 0.11
- MACD
- SGMO 0.02
- XBP -0.03
- Stochastic Oscillator
- SGMO 67.74
- XBP 13.44
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.